Source: International Congress 2019 – Oxidative stress, hypoxia and microbial exposure in the pathogenesis of pulmonary disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Soodaeva (Moscow, Russian Federation), E. Zaprudnova (Vladimir, Russian Federation), M. Smirnov (Vladimir, Russian Federation), . Klimanov (Moscow, Russian Federation), T. Li (Moscow, Russian Federation), N. Popova (Moscow, Russian Federation), L. Murakaeva (Moscow, Russian Federation), M. Glukhova (Moscow, Russian Federation), N. Kubysheva (Kazan, Russian Federation). Dynamics of free radical indicators of exhaled breath condensate in smokers.. 4103

Member's Comments

No comment yet.

Related content which might interest you: The markers of free radical oxidation in exhaled breath condensate (EBC) during the long-term smoking Source: Annual Congress 2009 - Tobacco smoke and inflammatory and immune effects Year: 2009 The dynamics of free radical parameters in exhaled breath condensate (EBC) in smokers during the course of physical workload Source: Annual Congress 2011 - Smoking-related diseases and smoking cessation Year: 2011 Parameters of oxidation in exhaled breath condensate Source: Eur Respir J 2004; 24: Suppl. 48, 470s Year: 2004 Influence of smoking on indicators of free-radical oxidation in a condensate in exhaled breath condensate (EBC) at healthy and patients with bronchial asthma (BA) Source: Annual Congress 2010 - Smoking related disorders Year: 2010 Determinants of variability in exhaled breath condensate (EBC) in children Source: Annual Congress 2008 - Inflammatory biomarkers Year: 2008 Increased 8-isoprostane in the exhaled breath condensate of down patients Source: Eur Respir J 2004; 24: Suppl. 48, 556s Year: 2004 Metabolomic/proteomic analysis of biomarkers in exhaled breath condensates Source: Annual Congress 2008 - PG8 - Cellular and molecular technologies of today - treatments of tomorrow Year: 2008 Dynamics of oxidative and antioxidant parameters of the exhaled air condensate in COPD. Source: International Congress 2018 – Functional genomics and COPD: new challenges Year: 2018 Detection and variability of cytokine-levels in exhaled breath condensate (EBC) of patients with stable COPD Source: Eur Respir J 2003; 22: Suppl. 45, 438s Year: 2003 Validation of eicosanoid measurements in exhaled breath condensate Source: Eur Respir J 2002; 20: Suppl. 38, 422s Year: 2002 Methodology of exhaled breath condensate Source: Annual Congress 2009 - Noninvasive monitoring of airway inflammation: beyond exhaled nitric oxide Year: 2009 Mathematic model of exhaled breath condensate forming Source: Eur Respir J 2006; 28: Suppl. 50, 422s Year: 2006 Separate lung exhaled breath condensate collection confirms intrapulmonary origin of exhaled breath condensate acidification Source: Eur Respir J 2007; 30: Suppl. 51, 364s Year: 2007 Technical problems with measurements of biomarkers - exhaled breath condensate Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases Year: 2017 Structures of an exhaled breath condensate in lung diseases Source: Eur Respir J 2005; 26: Suppl. 49, 525s Year: 2005 Quantitative analysis of 8-isoprostane and hydrogen peroxide in exhaled breath condensate Source: Eur Respir J 2004; 23: 189-192 Year: 2004 Nitrite/nitrate in exhaled breath condensate (EBC) of patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 671s Year: 2006 Reproducibility of exhaled breath condensate markers Source: Eur Respir J 2008; 32: Year: 2008